OUR STRATEGY
The strategy of the Galenica Group is characterised by two key elements: firstly, a consistent focus on one particular sector – the healthcare market, and secondly, a steady diversification of activities over years with a view to achieving a sensible distribution of risk. In this context, strategic decisions are always geared to the long-term development of the Group.
Strategy of the Galenica Group
_The core of Specialty Pharma is the fully integrated specialty pharma group Vifor Pharma. Vifor Pharma researches, develops and produces its own as well as inlicensed pharmaceutical products and markets them worldwide. Vifor Pharma has three key business areas: iron deficiency and iron deficiency anaemia, which accompanies a large number of diseases, the activities of the pharmaceutical company OM Pharma and its infectious diseases/OTX products and Consumer Healthcare, with a focus on OTC products.
_The «Swiss HealthCare Services» strategic axis is focused on a business model with integrated services for the Swiss healthcare market. This business model includes various pharmacy formats, pharmaceutical logistics and information management.
_Since 1999 the Galenica Group has had a strategic partnership with Alliance UniChem Plc, today Alliance Boots.
Contact
Downloads
Links
- Home
- About Galenica
- Strategy